인쇄하기
취소

SK Chemical is approved on the ‘Cell Culture-type Flu Vaccine’ for the first time in Korea and the third time internationally

Published: 2014-12-30 13:58:40
Updated: 2014-12-30 13:58:40

SK Chemical (executive director and CEO Man-hoon Park) announced that the company acquired a product license for the first cell culture-type flu vaccine ‘skyCellflu’ in Korea from the Ministry of Food and Drug Safety on the 26th. This is the third commercialized success after Norvatis and Baxter.

The cell culture method is a technique to cultivate virus using animal cells, instead of fertile c...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.